Loperamide, sold under the brand name Imodium, among others, is a medication used to decrease the frequency of diarrhea. It is often used for this purpose in inflammatory bowel disease and short bowel syndrome.
This report contains market size and forecasts of Loperamide in global, including the following market information:
Global Loperamide Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Loperamide Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Loperamide companies in 2021 (%)
The global Loperamide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Capsule Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Loperamide include Johnson & Johnson, Mylan, Bionpharma, Teva, Perrigo, Sun Pharmaceutical, Aurobindo Pharma and LNK International, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Loperamide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Loperamide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Loperamide Market Segment Percentages, by Type, 2021 (%)
Capsule
Tablet
Solution
Granule
Global Loperamide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Loperamide Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Pharmacies
Global Loperamide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Loperamide Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Loperamide revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Loperamide revenues share in global market, 2021 (%)
Key companies Loperamide sales in global market, 2017-2022 (Estimated), (MT)
Key companies Loperamide sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Mylan
Bionpharma
Teva
Perrigo
Sun Pharmaceutical
Aurobindo Pharma
LNK International